Contact

All Stories

  1. The Inhibition of Gag-Pol Expression by the Restriction Factor Shiftless Is Dispensable for the Restriction of HIV-1 Infection

    Article • Viruses, April 2024, MDPI AG

    Professor Stefan Pöhlmann

  2. Diversification of the VH3‐53 immunoglobulin gene segment by somatic hypermutation results in neutralization of SARS‐CoV‐2 virus variants

    Article • European Journal of Immunology, April 2024, Wiley

    Professor Stefan Pöhlmann

  3. Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany

    Article • The Lancet Infectious Diseases, March 2024, Elsevier

    Professor Stefan Pöhlmann

  4. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency

    Article • Cell, February 2024, Elsevier

    Professor Stefan Pöhlmann

  5. Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage

    Article • Cellular and Molecular Immunology, May 2023, Springer Science + Business Media

    Professor Stefan Pöhlmann

  6. Development of immortalized rhesus macaque kidney cells supporting infection with a panel of viruses

    Article • PLoS ONE, May 2023, PLOS

    Professor Stefan Pöhlmann

  7. Discovery of Polyphenolic Natural Products as SARS-CoV-2 Mpro Inhibitors for COVID-19

    Article • Pharmaceuticals, January 2023, MDPI AG

    Professor Stefan Pöhlmann

  8. TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection

    Article • Viruses, January 2023, MDPI AG

    Professor Stefan Pöhlmann

  9. Primate Simplexviruses Differ in Tropism for Macaque Cells

    Article • Microorganisms, December 2022, MDPI AG

    Professor Stefan Pöhlmann

  10. Discovery of Polyphenolic Natural Products as SARS-CoV-2 Mpro Inhibitors for COVID-19

    Article • November 2022, MDPI AG

    Professor Stefan Pöhlmann

  11. The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant

    Article • International Journal of Molecular Sciences, November 2022, MDPI AG

    Professor Stefan Pöhlmann

  12. Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1

    Article • Viruses, November 2022, MDPI AG

    Professor Stefan Pöhlmann

  13. Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2

    Article • Microbiology Spectrum, October 2022, ASM Journals

    Professor Stefan Pöhlmann

  14. Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment

    Article • Cell Research, September 2022, Springer Science + Business Media

    Professor Stefan Pöhlmann

  15. BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19

    Article • Nature Communications, August 2022, Springer Science + Business Media

    Professor Stefan Pöhlmann

  16. BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults

    Article • Frontiers in Immunology, July 2022, Frontiers

    Professor Stefan Pöhlmann

  17. Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruse...

    Article • Viruses, July 2022, MDPI AG

    Professor Stefan Pöhlmann

  18. Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture

    Article • Communications Biology, July 2022, Springer Science + Business Media

    Professor Stefan Pöhlmann

  19. Mutagenic Analysis of the HIV Restriction Factor Shiftless

    Article • Viruses, June 2022, MDPI AG

    Professor Stefan Pöhlmann

  20. Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy

    Article • mBio, June 2022, ASM Journals

    Professor Stefan Pöhlmann

  21. Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure–Activity Relationships, Antiviral Activity, and X-ray Structure Determination

    Article • Journal of Medicinal Chemistry, June 2022, American Chemical Society (ACS)

    Professor Stefan Pöhlmann

  22. Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3

    Article • The Lancet Infectious Diseases, June 2022, Elsevier

    Professor Stefan Pöhlmann

  23. Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2

    Article • Cellular and Molecular Immunology, May 2022, Springer Science + Business Media

    Professor Stefan Pöhlmann

  24. Understanding Omicron: Transmissibility, immune evasion and antiviral intervention

    Article • Clinical and Translational Medicine, May 2022, Wiley

    Professor Stefan Pöhlmann

  25. SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies

    Article • Cell Host & Microbe, May 2022, Elsevier

    Professor Stefan Pöhlmann

  26. SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination

    Article • Cell Reports, May 2022, Elsevier

    Professor Stefan Pöhlmann

  27. Investigations on SARS-CoV-2 Susceptibility of Domestic and Wild Animals Using Primary Cell Culture Models Derived from the Upper and Lower Respiratory Tract

    Article • Viruses, April 2022, MDPI AG

    Professor Stefan Pöhlmann

  28. Omicron: Master of immune evasion maintains robust ACE2 binding

    Article • Signal Transduction and Targeted Therapy, April 2022, Springer Science + Business Media

    Professor Stefan Pöhlmann

  29. Functional analysis of polymorphisms at the S1/S2 site of SARS-CoV-2 spike protein

    Article • PLoS ONE, March 2022, PLOS

    Professor Stefan Pöhlmann

  30. Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies

    Article • European Journal of Immunology, March 2022, Wiley

    Professor Stefan Pöhlmann

  31. Neutralizing antibody responses 300 days after SARS‐CoV‐2 infection and induction of high antibody titers after vaccination

    Article • European Journal of Immunology, March 2022, Wiley

    Professor Stefan Pöhlmann

  32. Alternatives to animal models and their application in the discovery of species susceptibility to SARS-CoV-2 and other respiratory infectious pathogens: A review

    Article • Veterinary Pathology, February 2022, SAGE Publications

    Professor Stefan Pöhlmann

  33. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

    Article • Cell, February 2022, Elsevier

    Professor Stefan Pöhlmann

  34. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases

    Article • Journal of Virology, January 2022, ASM Journals

    Professor Stefan Pöhlmann

  35. MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination

    Article • Cellular and Molecular Immunology, January 2022, Springer Science + Business Media

    Professor Stefan Pöhlmann

  36. No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2

    Article • Cellular and Molecular Immunology, January 2022, Springer Science + Business Media

    Professor Stefan Pöhlmann

  37. A Recombinant System and Reporter Viruses for Papiine Alphaherpesvirus 2

    Article • Viruses, January 2022, MDPI AG

    Professor Stefan Pöhlmann

  38. The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses

    Article • Cellular and Molecular Life Sciences, January 2022, Springer Science + Business Media

    Professor Stefan Pöhlmann

  39. Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants

    Article • EBioMedicine, January 2022, Elsevier

    Professor Stefan Pöhlmann

  40. Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies

    Article • Frontiers in Immunology, December 2021, Frontiers

    Professor Stefan Pöhlmann

  41. Novel SARS-CoV-2 receptors: ASGR1 and KREMEN1

    Article • Cell Research, December 2021, Springer Science + Business Media

    Professor Stefan Pöhlmann

  42. Erythrocytes increase endogenous sphingosine 1-phosphate levels as an adaptive response to SARS-CoV-2 infection

    Article • Clinical Science, December 2021, Portland Press Ltd.

    Professor Stefan Pöhlmann

  43. Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease

    Article • Kidney International, December 2021, Elsevier

    Professor Stefan Pöhlmann

  44. Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization

    Article • Nature Communications, November 2021, Springer Science + Business Media

    Professor Stefan Pöhlmann

  45. Spike residue 403 affects binding of coronavirus spikes to human ACE2

    Article • Nature Communications, November 2021, Springer Science + Business Media

    Professor Stefan Pöhlmann

  46. The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency

    Article • Cellular and Molecular Immunology, October 2021, Springer Science + Business Media

    Professor Stefan Pöhlmann

  47. Evidence that two instead of one defective interfering RNA in influenza A virus-derived defective interfering particles (DIPs) does not enhance antiviral activity

    Article • Scientific Reports, October 2021, Springer Science + Business Media

    Professor Stefan Pöhlmann

  48. A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells

    Article • Proceedings of the National Academy of Sciences, October 2021, Proceedings of the National Academy of Sciences

    Professor Stefan Pöhlmann

  49. Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance

    Article • Cellular and Molecular Immunology, October 2021, Springer Science + Business Media

    Professor Stefan Pöhlmann

  50. B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination

    Article • Cell Reports, October 2021, Elsevier

    Professor Stefan Pöhlmann

  51. The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 Infection

    Article • International Journal of Molecular Sciences, September 2021, MDPI AG

    Professor Stefan Pöhlmann

  52. A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model

    Article • European Journal of Immunology, September 2021, Wiley

    Professor Stefan Pöhlmann

  53. Functional comparison of MERS-coronavirus lineages reveals increased replicative fitness of the recombinant lineage 5

    Article • Nature Communications, September 2021, Springer Science + Business Media

    Professor Stefan Pöhlmann

  54. SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination

    Article • The Lancet, September 2021, Elsevier

    Professor Stefan Pöhlmann

  55. Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination

    Article • Cellular and Molecular Immunology, August 2021, Springer Science + Business Media

    Professor Stefan Pöhlmann

  56. Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination

    Article • Nature Medicine, July 2021, Springer Science + Business Media

    Professor Stefan Pöhlmann

  57. SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants

    Article • PLoS Medicine, July 2021, PLOS

    Professor Stefan Pöhlmann, Dr David Ross Darley

  58. SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination

    Article • Cell Reports, July 2021, Elsevier

    Professor Stefan Pöhlmann

  59. How SARS-CoV-2 makes the cut

    Article • Nature Microbiology, June 2021, Springer Science + Business Media

    Professor Stefan Pöhlmann

  60. Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination

    Article • Clinical Infectious Diseases, June 2021, Oxford University Press (OUP)

    Professor Stefan Pöhlmann

  61. Urinary Levels of SARS-CoV-2 Nucleocapsid Protein Associate With Risk of AKI and COVID-19 Severity: A Single-Center Observational Study

    Article • Frontiers in Medicine, May 2021, Frontiers

    Professor Stefan Pöhlmann

  62. Therapeutic Application of alpha-1-antitrypsin in COVID-19

    Article • American Journal of Respiratory and Critical Care Medicine, May 2021, American Thoracic Society

    Professor Stefan Pöhlmann

  63. Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles

    Article • BMC Biology, May 2021, Springer Science + Business Media

    Professor Stefan Pöhlmann

  64. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways

    Article • PLoS Pathogens, April 2021, PLOS

    Professor Stefan Pöhlmann, Lieve Naesens

  65. SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization

    Article • Cell Reports, April 2021, Elsevier

    Professor Stefan Pöhlmann

  66. The sphingosine kinase 1 activator, K6PC-5, attenuates Ebola virus infection

    Article • iScience, April 2021, Elsevier

    Professor Stefan Pöhlmann

  67. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

    Article • Cell, April 2021, Elsevier

    Professor Stefan Pöhlmann

  68. Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection

    Article • Nature Communications, March 2021, Springer Science + Business Media

    Professor Stefan Pöhlmann

  69. Ex vivo assay to evaluate the efficacy of drugs targeting sphingolipids in preventing SARS-CoV-2 infection of nasal epithelial cells

    Article • STAR Protocols, March 2021, Elsevier

    Professor Stefan Pöhlmann

  70. Mutation D614G increases SARS-CoV-2 transmission

    Article • Signal Transduction and Targeted Therapy, March 2021, Springer Science + Business Media

    Professor Stefan Pöhlmann

  71. Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity

    Article • EBioMedicine, March 2021, Elsevier

    Professor Stefan Pöhlmann

  72. Dalbavancin: novel candidate for COVID-19 treatment

    Article • Cell Research, January 2021, Springer Science + Business Media

    Professor Stefan Pöhlmann

  73. Natural cystatin C fragments inhibit GPR15-mediated HIV and SIV infection without interfering with GPR15L signaling

    Article • Proceedings of the National Academy of Sciences, January 2021, Proceedings of the National Academy of Sciences

    Professor Stefan Pöhlmann

  74. Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostat

    Article • Chemical Science, January 2021, Royal Society of Chemistry

    Professor Stefan Pöhlmann

  75. Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells

    Article • Journal of Biological Chemistry, January 2021, Elsevier

    Professor Stefan Pöhlmann

  76. Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties

    Article • Chemical Science, January 2021, Royal Society of Chemistry

    Professor Stefan Pöhlmann

  77. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways

    Article • November 2020, Cold Spring Harbor Laboratory Press

    Professor Stefan Pöhlmann

  78. Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods

    Article • Cellular and Molecular Immunology, November 2020, Springer Science + Business Media

    Professor Stefan Pöhlmann

  79. Corrigendum: Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein–Ligand Interactions

    Article • Angewandte Chemie International Edition, November 2020, Wiley

    Professor Stefan Pöhlmann

  80. Camostat Mesylate May Reduce Severity of Coronavirus Disease 2019 Sepsis: A First Observation

    Article • Critical Care Explorations, November 2020, Wolters Kluwer Health

    Professor Stefan Pöhlmann

  81. Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells

    Article • Cell Reports Medicine, November 2020, Elsevier

    Professor Stefan Pöhlmann

  82. Sphingosine prevents binding of SARS–CoV-2 spike to its cellular receptor ACE2

    Article • Journal of Biological Chemistry, November 2020, Elsevier

    Professor Stefan Pöhlmann

  83. Glycan-Gold Nanoparticles as Multifunctional Probes for Multivalent Lectin–Carbohydrate Binding: Implications for Blocking Virus Infection and Nanoparticle Assembly

    Article • Journal of the American Chemical Society, September 2020, American Chemical Society (ACS)

    Professor Stefan Pöhlmann

  84. LY6E impairs coronavirus fusion and confers immune control of viral disease

    Article • Nature Microbiology, July 2020, Springer Science + Business Media

    Professor Stefan Pöhlmann

  85. Chloroquine does not inhibit SARS-CoV-2

    Article • Nature, July 2020, Springer Science + Business Media

    Professor Stefan Pöhlmann

  86. Probing Multivalent Lectin-Carbohydrate Binding via Multifunctional Glycan-Gold Nanoparticles: Implications for Blocking Virus Infection

    Article • June 2020, American Chemical Society (ACS)

    Professor Stefan Pöhlmann

  87. Probing Multivalent Lectin-Carbohydrate Binding via Multifunctional Glycan-Gold Nanoparticles: Implications for Blocking Virus Infection

    Article • June 2020, American Chemical Society (ACS)

    Professor Stefan Pöhlmann

  88. Furin cleavage of SARS-CoV-2 spike is required for infection of lung cells

    Article • Molecular Cell, May 2020, Elsevier

    Professor Stefan Pöhlmann

  89. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

    Article • Cell, May 2020, Elsevier

    Professor Stefan Pöhlmann

  90. H2 influenza A virus is not pathogenic in Tmprss2 knock-out mice

    Article • Virology Journal, April 2020, Springer Science + Business Media

    Professor Stefan Pöhlmann

  91. Nafamostat inhibits SARS-CoV-2

    Article • Antimicrobial Agents and Chemotherapy, April 2020, ASM Journals

    Professor Stefan Pöhlmann

  92. SARS-CoV-2 uses ACE2 and TMPRSS2 for infection of lung cells

    Article • Cell, April 2020, Elsevier

    Professor Stefan Pöhlmann

  93. SARS-CoV-2 uses ACE2 and TMPRSS2 for infection of lung cells

    Article • January 2020, Cold Spring Harbor Laboratory Press

    Professor Stefan Pöhlmann

  94. Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus

    Article • Emerging Microbes & Infections, January 2020, Taylor & Francis

    Professor Stefan Pöhlmann

  95. A Fosmid-Based System for the Generation of Recombinant Cercopithecine Alphaherpesvirus 2 Encoding Reporter Genes

    Article • Viruses, November 2019, MDPI AG

    Professor Stefan Pöhlmann

  96. Role of rhesus macaque IFITM3(2) in simian immunodeficiency virus infection of macaques

    Article • PLoS ONE, November 2019, PLOS

    Professor Stefan Pöhlmann

  97. Analysis of Resistance of Ebola Virus Glycoprotein-Driven Entry Against MDL28170, An Inhibitor of Cysteine Cathepsins

    Article • Pathogens, October 2019, MDPI AG

    Professor Stefan Pöhlmann

  98. Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influenza B Virus for Replication in Human Airways

    Article • Journal of Virology, October 2019, ASM Journals

    Professor Stefan Pöhlmann

  99. Spike proteins of novel MERS-coronavirus isolates from North- and West-African dromedary camels mediate robust viral entry into human target cells

    Article • Virology, September 2019, Elsevier

    Professor Stefan Pöhlmann

  100. Evidence for influenza B virus hemagglutinin adaptation to the human host: high cleavability, acid-stability and preference for cool temperature

    Article • August 2019, Cold Spring Harbor Laboratory Press

    Professor Stefan Pöhlmann

  101. Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay

    Article • International Journal of Molecular Sciences, August 2019, MDPI AG

    Professor Stefan Pöhlmann

  102. Kaposi sarcoma in a guereza monkey

    Article • Emerging Infectious Diseases, August 2019, Centers for Disease Control and Prevention (CDC)

    Professor Stefan Pöhlmann

  103. Novel Virus Related to Kaposi’s Sarcoma–Associated Herpesvirus from Colobus Monkey

    Article • Emerging Infectious Diseases, August 2019, Centers for Disease Control and Prevention (CDC)

    Professor Stefan Pöhlmann

  104. Evidence that Calu-3 cells are largely resistant to Ebola virus entry

    Article • Virology, June 2019, Elsevier

    Professor Stefan Pöhlmann

  105. Tmprss2 knock-out mice are resistant to H10 influenza A virus pathogenesis

    Article • Journal of General Virology, May 2019, Society for General Microbiology

    Professor Stefan Pöhlmann

  106. IFITM s mediate viral evasion in acute and chronic hepatitis C virus infection

    Article • Hepatology, May 2019, Wiley

    Professor Stefan Pöhlmann

  107. Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope Proteins

    Article • Cell Reports, May 2019, Elsevier

    Professor Stefan Pöhlmann

  108. SPP and SKI-1 inhibitor block Ebola virus entry

    Article • PLoS ONE, April 2019, PLOS

    Professor Stefan Pöhlmann

  109. Modulation of HIV-1 Gag/Gag-Pol frameshifting by tRNA abundance

    Article • Nucleic Acids Research, April 2019, Oxford University Press (OUP)

    Professor Stefan Pöhlmann

  110. Detection of antibodies against viruses in a macaque colony using a chip-based approach

    Article • Primate Biology, March 2019, Copernicus GmbH

    Professor Stefan Pöhlmann

  111. The cell Line SH-SY5Y is resistant to infection by Ebola virus and other filoviruses

    Article • Viruses, March 2019, MDPI AG

    Professor Stefan Pöhlmann

  112. A safe system for production of defective interfering particles

    Article • PLoS ONE, March 2019, PLOS

    Professor Stefan Pöhlmann

  113. Virosomes interfere with Ebola virus control by the immune system

    Article • Cell Reports, February 2019, Elsevier

    Professor Stefan Pöhlmann

  114. Focal epithelial hyperplasia and papillomavirus infection in a bonobo

    Article • Pathogens, January 2019, MDPI AG

    Professor Stefan Pöhlmann

  115. Development and use of Lentiviral Vectors Pseudotyped with Influenza B Haemagglutinins: application to vaccine immunogenicity, mAb potency and sero-surveillance studies

    Article • December 2018, Cold Spring Harbor Laboratory Press

    Professor Stefan Pöhlmann, Professor Nigel James Temperton

  116. Tetherin efficiently inhibits Nipah virus but not Ebola virus spread in fruit bat cells

    Article • Journal of Virology, November 2018, ASM Journals

    Professor Stefan Pöhlmann

  117. MERS-coronavirus spike protein: Importance of protease cleavage sites for viral entry

    Article • Scientific Reports, November 2018, Springer Science + Business Media

    Professor Stefan Pöhlmann

  118. A MERS-coronavirus variant that is partially resistant against neutralizing antibodies

    Article • Journal of Virology, November 2018, ASM Journals

    Professor Stefan Pöhlmann

  119. The cellular protease TMPRSS11A can convert influenza virus into an infectious form

    Article • Journal of Biological Chemistry, July 2018, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Stefan Pöhlmann

  120. Cell Entry of Influenza A Viruses: Sweet Talk between HA and Ca V 1.2

    Article • Cell Host & Microbe, June 2018, Elsevier

    Professor Stefan Pöhlmann

  121. A GXXXA motif in the Ebola virus glycoprotein is required for tetherin antagonism

    Article • Journal of Virology, April 2018, ASM Journals

    Professor Stefan Pöhlmann

  122. Attachment/Binding

    Article • January 2018, Springer Science + Business Media

    Professor Stefan Pöhlmann

  123. VSV-G antagonizes tetherin in transfected cells

    Article • PLoS ONE, December 2017, PLOS

    Professor Stefan Pöhlmann

  124. Inhibition of lectin-dependent enhancement of Ebola virus entry into cells

    Article • Journal of the American Chemical Society, August 2017, American Chemical Society (ACS)

    Professor Stefan Pöhlmann

  125. Identification of sites in SARS-S required cleavage and activation by TMPRSS2

    Article • PLoS ONE, June 2017, PLOS

    Professor Stefan Pöhlmann

  126. TMPRSS2 of non-human primates activates influenza viruses

    Article • PLoS ONE, May 2017, PLOS

    Professor Stefan Pöhlmann

  127. Herpes B virus replication and viral lesions in the liver of a cynomolgus macaque which died from severe disease with rapid onset

    Article • Journal of Medical Primatology, April 2017, Wiley

    Professor Stefan Pöhlmann

  128. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs

    Article • Journal of Virology, March 2017, ASM Journals

    Dr Mikhail N Matrosovich, Professor Stefan Pöhlmann

  129. Rhesus macaque IFITM3 gene polymorphisms and SIV infection

    Article • PLoS ONE, March 2017, PLOS

    Professor Stefan Pöhlmann

  130. A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulates Host Cell Entry

    Article • Journal of Virology, February 2017, ASM Journals

    Professor Stefan Pöhlmann

  131. Detection systems for antibody responses against herpes B virus

    Article • Primate Biology, February 2017, Copernicus GmbH

    Professor Stefan Pöhlmann

  132. Evidence that Processing of the Severe Fever with Thrombocytopenia Syndrome Virus Gn/Gc Polyprotein Is Critical for Viral Infectivity and Requires an Internal Gc Signal Peptide

    Article • PLoS ONE, November 2016, PLOS

    Professor Stefan Pöhlmann

  133. Virion Background and Efficiency of Virion Incorporation Determine Susceptibility of Simian Immunodeficiency Virus Env-Driven Viral Entry to Inhibition by IFITM Proteins

    Article • Journal of Virology, November 2016, ASM Journals

    Professor Stefan Pöhlmann

  134. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies

    Article • Journal of Virology, October 2016, ASM Journals

    Professor Stefan Pöhlmann

  135. The Role of Phlebovirus Glycoproteins in Viral Entry, Assembly and Release

    Article • Viruses, July 2016, MDPI AG

    Professor Stefan Pöhlmann

  136. The Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-Dependent Entry into Bat but Not Human Cells

    Article • PLoS ONE, March 2016, PLOS

    Professor Stefan Pöhlmann

  137. Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein-Ligand Interactions

    Article • Angewandte Chemie International Edition, March 2016, Wiley

    Professor Stefan Pöhlmann

  138. Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein-Ligand Interactions

    Article • Angewandte Chemie, March 2016, Wiley

    Professor Stefan Pöhlmann

  139. The Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat and Human Cells but Entry Efficiency Is Species Dependent

    Article • PLoS ONE, February 2016, PLOS

    Professor Stefan Pöhlmann

  140. The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases

    Article • Journal of Virology, February 2016, ASM Journals

    Professor Stefan Pöhlmann

  141. TMPRSS2 Isoform 1 Activates Respiratory Viruses and Is Expressed in Viral Target Cells

    Article • PLoS ONE, September 2015, PLOS

    Professor Stefan Pöhlmann

  142. Exclusive Decoration of Simian Immunodeficiency Virus Env with High-Mannose Type N-Glycans Is Not Compatible with Mucosal Transmission in Rhesus Macaques

    Article • Journal of Virology, September 2015, ASM Journals

    Professor Stefan Pöhlmann

  143. Tetherin Sensitivity of Influenza A Viruses Is Strain Specific: Role of Hemagglutinin and Neuraminidase

    Article • Journal of Virology, June 2015, ASM Journals

    Professor Stefan Pöhlmann

  144. Interferon-Induced Transmembrane Protein–Mediated Inhibition of Host Cell Entry of Ebolaviruses

    Article • The Journal of Infectious Diseases, June 2015, Oxford University Press (OUP)

    Professor Stefan Pöhlmann

  145. Analysis of Ebola Virus Entry Into Macrophages

    Article • The Journal of Infectious Diseases, April 2015, Oxford University Press (OUP)

    Professor Stefan Pöhlmann

  146. Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976

    Article • The Journal of Infectious Diseases, April 2015, Oxford University Press (OUP)

    Professor Stefan Pöhlmann

  147. Protease inhibitors targeting coronavirus and filovirus entry

    Article • Antiviral Research, April 2015, Elsevier

    Professor Adam Robert Renslo, Professor Stefan Pöhlmann

  148. IFITM Proteins Inhibit Entry Driven by the MERS-Coronavirus Spike Protein: Evidence for Cholesterol-Independent Mechanisms

    Article • Viruses, September 2014, MDPI AG

    Professor Stefan Pöhlmann

  149. DESC1 and MSPL Activate Influenza A Viruses and Emerging Coronaviruses for Host Cell Entry

    Article • Journal of Virology, August 2014, ASM Journals

    Professor Stefan Pöhlmann

  150. Inhibition of Proprotein Convertases Abrogates Processing of the Middle Eastern Respiratory Syndrome Coronavirus Spike Protein in Infected Cells but Does Not Reduce Viral Infectivity

    Article • The Journal of Infectious Diseases, July 2014, Oxford University Press (OUP)

    Professor Stefan Pöhlmann

  151. Bitter-sweet symphony: glycan–lectin interactions in virus biology

    Article • FEMS Microbiology Reviews, July 2014, Oxford University Press (OUP)

    Professor Stefan Pöhlmann, Professor Hans Jan Nauwynck

  152. Influenza A Virus Encoding Secreted Gaussia Luciferase as Useful Tool to Analyze Viral Replication and Its Inhibition by Antiviral Compounds and Cellular Proteins

    Article • PLoS ONE, May 2014, PLOS

    Professor Stefan Pöhlmann

  153. Analysis of Determinants in Filovirus Glycoproteins Required for Tetherin Antagonism

    Article • Viruses, April 2014, MDPI AG

    Professor Stefan Pöhlmann

  154. The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry

    Article • Journal of Antimicrobial Chemotherapy, April 2014, Oxford University Press (OUP)

    Professor Stefan Pöhlmann

  155. Induced and spontaneous heart rate turbulence in mice: influence of coupling interval

    Article • EP Europace, March 2014, European Society of Cardiology

    Professor Stefan Pöhlmann

  156. Toll-Like Receptor 3 Signalling Up-Regulates Expression of the HIV Co-Receptor G-Protein Coupled Receptor 15 on Human CD4+ T Cells

    Article • PLoS ONE, February 2014, PLOS

    Professor Stefan Pöhlmann

  157. Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice

    Article • PLoS Pathogens, December 2013, PLOS

    Professor Stefan Pöhlmann

  158. Lack of MERS Coronavirus Neutralizing Antibodies in Humans, Eastern Province, Saudi Arabia

    Article • Emerging Infectious Diseases, December 2013, Centers for Disease Control and Prevention (CDC)

    Professor Stefan Pöhlmann

  159. Proteolytic activation of the SARS-coronavirus spike protein: Cutting enzymes at the cutting edge of antiviral research

    Article • Antiviral Research, December 2013, Elsevier

    Professor Stefan Pöhlmann

  160. TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein

    Article • Journal of Virology, November 2013, ASM Journals

    Professor Stefan Pöhlmann

  161. Platelet activation suppresses HIV-1 infection of T cells

    Article • Retrovirology, May 2013, Springer Science + Business Media

    Professor Stefan Pöhlmann

  162. TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry and Is Expressed in Viral Target Cells in the Respiratory Epithelium

    Article • Journal of Virology, March 2013, ASM Journals

    Professor Stefan Pöhlmann

  163. The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies

    Article • Journal of Virology, March 2013, ASM Journals

    Professor Stefan Pöhlmann

  164. Severe Fever with Thrombocytopenia Virus Glycoproteins Are Targeted by Neutralizing Antibodies and Can Use DC-SIGN as a Receptor for pH-Dependent Entry into Human and Animal Cell Lines

    Article • Journal of Virology, February 2013, ASM Journals

    Professor Stefan Pöhlmann

  165. Cellular Entry of Retroviruses

    Article • January 2013, Springer Science + Business Media

    Professor Stefan Pöhlmann

  166. Attachment/Binding

    Article • January 2013, Springer Science + Business Media

    Professor Stefan Pöhlmann

  167. Host Cell Factors in Filovirus Entry: Novel Players, New Insights

    Article • Viruses, November 2012, MDPI AG

    Professor Stefan Pöhlmann

  168. The role of the alternative coreceptor GPR15 in SIV tropism for human cells

    Article • Virology, November 2012, Elsevier

    Professor Stefan Pöhlmann

  169. How Ebola Virus Counters the Interferon System

    Article • Zoonoses and Public Health, September 2012, Wiley

    Professor Stefan Pöhlmann

  170. Influenza A Virus Does Not Encode a Tetherin Antagonist with Vpu-Like Activity and Induces IFN-Dependent Tetherin Expression in Infected Cells

    Article • PLoS ONE, August 2012, PLOS

    Professor Stefan Pöhlmann

  171. Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts

    Article • PLoS ONE, April 2012, PLOS

    Professor Stefan Pöhlmann

  172. Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression

    Article • Virology, March 2012, Elsevier

    Professor Stefan Pöhlmann

  173. CD4- and dynamin-dependent endocytosis of HIV-1 into plasmacytoid dendritic cells

    Article • Virology, February 2012, Elsevier

    Professor Stefan Pöhlmann

  174. Comparative Analysis of Ebola Virus Glycoprotein Interactions With Human and Bat Cells

    Article • The Journal of Infectious Diseases, November 2011, Oxford University Press (OUP)

    Professor Stefan Pöhlmann

  175. The Ebola Virus Glycoprotein and HIV-1 Vpu Employ Different Strategies to Counteract the Antiviral Factor Tetherin

    Article • The Journal of Infectious Diseases, November 2011, Oxford University Press (OUP)

    Professor Stefan Pöhlmann

  176. The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors

    Article • PLoS Pathogens, October 2011, PLOS

    Professor Stefan Pöhlmann, Friedemann Weber

  177. Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like Protease

    Article • Journal of Virology, October 2011, ASM Journals

    Professor Stefan Pöhlmann

  178. DC-SIGN: Access Portal for Sweet Viral Killers

    Article • Cell Host & Microbe, July 2011, Elsevier

    Professor Stefan Pöhlmann

  179. Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion

    Article • Virology, May 2011, Elsevier

    Professor Stefan Pöhlmann

  180. Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response

    Article • Journal of Virology, February 2011, ASM Journals

    Professor Stefan Pöhlmann

  181. Mouse LSECtin as a model for a human Ebola virus receptor

    Article • Glycobiology, January 2011, Oxford University Press (OUP)

    Professor Stefan Pöhlmann

  182. The multiple facets of HIV attachment to dendritic cell lectins

    Article • Cellular Microbiology, September 2010, Hindawi Publishing Corporation

    Professor Stefan Pöhlmann

  183. Novel insights into proteolytic cleavage of influenza virus hemagglutinin

    Article • Reviews in Medical Virology, August 2010, Wiley

    Professor Stefan Pöhlmann

  184. TMPRSS2 and TMPRSS4 Facilitate Trypsin-Independent Spread of Influenza Virus in Caco-2 Cells

    Article • Journal of Virology, July 2010, ASM Journals

    Professor Stefan Pöhlmann

  185. A Single Asparagine-Linked Glycosylation Site of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Facilitates Inhibition by Mannose-Binding Lectin through Multiple Mechanisms

    Article • Journal of Virology, June 2010, ASM Journals

    Professor Stefan Pöhlmann

  186. Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2

    Article • Retrovirology, May 2010, Springer Science + Business Media

    Professor Stefan Pöhlmann

  187. Peptide-Based Inhibitors of the HIV Envelope Protein and Other Class I Viral Fusion Proteins

    Article • Current Pharmaceutical Design, March 2010, Bentham Science Publishers

    Professor Stefan Pöhlmann

  188. Calcium-modulating cyclophilin ligand does not restrict retrovirus release

    Article • Nature Medicine, February 2010, Springer Science + Business Media

    Professor Stefan Pöhlmann

  189. Lectin-like interactions in virus–cell recognition

    Article • January 2010, Elsevier

    Professor Stefan Pöhlmann

  190. Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63

    Article • Journal of Virology, October 2009, ASM Journals

    Friedemann Weber, Professor Stefan Pöhlmann

  191. Cellular Entry of the SARS Coronavirus: Implications for Transmission, Pathogenicity and Antiviral Strategies

    Article • October 2009, Springer Science + Business Media

    Professor Stefan Pöhlmann

  192. Type II transmembrane serine proteases in cancer and viral infections

    Article • Trends in Molecular Medicine, July 2009, Elsevier

    Professor Stefan Pöhlmann

  193. Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin

    Article • Journal of Virology, January 2009, ASM Journals

    Professor Stefan Pöhlmann, Dr Makoto Takeda

  194. Carbohydrates on HIV: mediators of immune evasion and targets for antiviral intervention

    Article • Future HIV Therapy, May 2008, Future Medicine

    Professor Stefan Pöhlmann

  195. Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral ligands: Differential pH dependence, internalization and virion binding

    Article • Virology, March 2008, Elsevier

    Professor Stefan Pöhlmann

  196. Analysis of the Interaction of Ebola Virus Glycoprotein with DC‐SIGN (Dendritic Cell–Specific Intercellular Adhesion Molecule 3–Grabbing Nonintegrin) and Its Homologue DC‐SIGNR

    Article • The Journal of Infectious Diseases, November 2007, Oxford University Press (OUP)

    Professor Stefan Pöhlmann

  197. A Novel Mechanism for LSECtin Binding to Ebola Virus Surface Glycoprotein through Truncated Glycans

    Article • Journal of Biological Chemistry, November 2007, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Stefan Pöhlmann

  198. Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectin

    Article • Virology, November 2007, Elsevier

    Professor Stefan Pöhlmann

  199. Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Peptide

    Article • Cell, April 2007, Elsevier

    Professor Stefan Pöhlmann

  200. A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo

    Article • Virology, April 2007, Elsevier

    Professor Stefan Pöhlmann, Professor Jonathan Luke Heeney

  201. The C-type Lectin Receptors CLEC-2 and Dectin-1, but Not DC-SIGN, Signal via a Novel YXXL-dependent Signaling Cascade

    Article • Journal of Biological Chemistry, March 2007, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Stefan Pöhlmann

  202. Attachment of human immunodeficiency virus to cells and its inhibition

    Article • January 2007, Springer Science + Business Media

    Professor Stefan Pöhlmann

  203. DC-SIGN and CLEC-2 Mediate Human Immunodeficiency Virus Type 1 Capture by Platelets

    Article • Journal of Virology, September 2006, ASM Journals

    Professor Stefan Pöhlmann

  204. Modulation of virion incorporation of Ebolavirus glycoprotein: Effects on attachment, cellular entry and neutralization

    Article • Virology, September 2006, Elsevier

    Professor Stefan Pöhlmann

  205. Highly Conserved Regions within the Spike Proteins of Human Coronaviruses 229E and NL63 Determine Recognition of Their Respective Cellular Receptors

    Article • Journal of Virology, September 2006, ASM Journals

    Professor Stefan Pöhlmann

  206. The Signal Peptide of the Ebolavirus Glycoprotein Influences Interaction with the Cellular Lectins DC-SIGN and DC-SIGNR

    Article • Journal of Virology, July 2006, ASM Journals

    Professor Stefan Pöhlmann

  207. Cellular Entry of HIV: Evaluation of Therapeutic Targets

    Article • Current Pharmaceutical Design, June 2006, Bentham Science Publishers

    Professor Stefan Pöhlmann

  208. Impact of polymorphisms in the DC-SIGNR neck domain on the interaction with pathogens

    Article • Virology, April 2006, Elsevier

    Professor Stefan Pöhlmann

  209. Functional comparison of mouse CIRE/mouse DC-SIGN and human DC-SIGN

    Article • International Immunology, March 2006, Oxford University Press (OUP)

    Professor Stefan Pöhlmann

  210. Evidence that multiple defects in murine DC-SIGN inhibit a functional interaction with pathogens

    Article • Virology, February 2006, Elsevier

    Professor Stefan Pöhlmann

  211. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2

    Article • Blood, January 2006, American Society of Hematology

    Professor Stefan Pöhlmann

  212. Interaction Between the Spike Protein of Human Coronavirus NL63 and its Cellular Receptor ACE2

    Article • January 2006, Springer Science + Business Media

    Professor Stefan Pöhlmann

  213. Attachment Factor and Receptor Engagement of Sars Coronavirus and Human Coronavirus NL63

    Article • January 2006, Springer Science + Business Media

    Professor Stefan Pöhlmann

  214. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus

    Article • Virology, September 2005, Elsevier

    Professor Stefan Pöhlmann

  215. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

    Article • Proceedings of the National Academy of Sciences, May 2005, Proceedings of the National Academy of Sciences

    Professor Stefan Pöhlmann

  216. DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus

    Article • Journal of Virology, November 2004, ASM Journals

    Professor Stefan Pöhlmann

  217. Cellular entry of the SARS coronavirus

    Article • Trends in Microbiology, October 2004, Elsevier

    Professor Stefan Pöhlmann

  218. Differential regulation of human immunodeficiency virus type 2 and simian immunodeficiency virus promoter activity

    Article • Virology, July 2004, Elsevier

    Professor Stefan Pöhlmann

  219. Prospects of HIV‐1 entry inhibitors as novel therapeutics

    Article • Reviews in Medical Virology, July 2004, Wiley

    Professor Stefan Pöhlmann

  220. Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor

    Article • Biochemical and Biophysical Research Communications, July 2004, Elsevier

    Professor Stefan Pöhlmann

  221. S Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Mediates Entry into Hepatoma Cell Lines and Is Targeted by Neutralizing Antibodies in Infected Patients

    Article • Journal of Virology, June 2004, ASM Journals

    Professor Stefan Pöhlmann

  222. Amino Acid 324 in the Simian Immunodeficiency Virus SIVmac V3 Loop Can Confer CD4 Independence and Modulate the Interaction with CCR5 and Alternative Coreceptors

    Article • Journal of Virology, April 2004, ASM Journals

    Professor Stefan Pöhlmann

  223. Mutations in the C3 region of human and simian immunodeficiency virus envelope have differential effects on viral infectivity, replication, and CD4-dependency

    Article • Virology, October 2003, Elsevier

    Professor Stefan Pöhlmann

  224. Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR

    Article • Journal of Virology, April 2003, ASM Journals

    Professor Stefan Pöhlmann

  225. Differential N-Linked Glycosylation of Human Immunodeficiency Virus and Ebola Virus Envelope Glycoproteins Modulates Interactions with DC-SIGN and DC-SIGNR

    Article • Journal of Virology, January 2003, ASM Journals

    Professor Stefan Pöhlmann

  226. DC-SIGN and DC-SIGNR Bind Ebola Glycoproteins and Enhance Infection of Macrophages and Endothelial Cells

    Article • Virology, January 2003, Elsevier

    Professor Stefan Pöhlmann

  227. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics

    Article • Proceedings of the National Academy of Sciences, November 2002, Proceedings of the National Academy of Sciences

    Professor Stefan Pöhlmann

  228. Diversity of receptors binding HIV on dendritic cell subsets

    Article • Nature Immunology, September 2002, Springer Science + Business Media

    Professor Stefan Pöhlmann

  229. Quantitative Expression and Virus Transmission Analysis of DC-SIGN on Monocyte-Derived Dendritic Cells

    Article • Journal of Virology, September 2002, ASM Journals

    Professor Stefan Pöhlmann

  230. The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?

    Article • Expert Opinion on Therapeutic Targets, August 2002, Informa Healthcare

    Professor Stefan Pöhlmann

  231. Hemofiltrate CC Chemokine 1[9-74] Causes Effective Internalization of CCR5 and Is a Potent Inhibitor of R5-Tropic Human Immunodeficiency Virus Type 1 Strains in Primary T Cells and Macrophages

    Article • Antimicrobial Agents and Chemotherapy, April 2002, ASM Journals

    Professor Stefan Pöhlmann

  232. CD4 Independence of Simian Immunodeficiency Virus Envs Is Associated with Macrophage Tropism, Neutralization Sensitivity, and Attenuated Pathogenicity

    Article • Journal of Virology, March 2002, ASM Journals

    Professor Stefan Pöhlmann

  233. Evaluation of Current Approaches to Inhibit HIV Entry

    Article • Current Drug Targets - Infectious Disorders, March 2002, Bentham Science Publishers

    Professor Stefan Pöhlmann

  234. Expression of DC-SIGN by Dendritic Cells of Intestinal and Genital Mucosae in Humans and Rhesus Macaques

    Article • Journal of Virology, February 2002, ASM Journals

    Professor Stefan Pöhlmann

  235. DC-SIGN and DC-SIGNR: helping hands for HIV

    Article • Trends in Immunology, December 2001, Elsevier

    Professor Stefan Pöhlmann

  236. Functional and Antigenic Characterization of Human, Rhesus Macaque, Pigtailed Macaque, and Murine DC-SIGN

    Article • Journal of Virology, November 2001, ASM Journals

    Professor Stefan Pöhlmann, Professor Tim D Sparwasser

  237. DC-SIGN Interactions with Human Immunodeficiency Virus: Virus Binding and Transfer Are Dissociable Functions

    Article • Journal of Virology, November 2001, ASM Journals

    Professor Stefan Pöhlmann

  238. Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV

    Article • The Journal of Pathology, October 2001, Wiley

    Professor Stefan Pöhlmann

  239. The Role of DC-SIGN and DC-SIGNR in HIV and SIV Attachment, Infection, and Transmission

    Article • Virology, July 2001, Elsevier

    Professor Stefan Pöhlmann

  240. Basic Amino Acid Residues in the V3 Loop of Simian Immunodeficiency Virus Envelope Alter Viral Coreceptor Tropism and Infectivity but Do Not Allow Efficient Utilization of CXCR4 as Entry Cofactor

    Article • Virology, June 2001, Elsevier

    Professor Stefan Pöhlmann

  241. DC-SIGN Interactions with Human Immunodeficiency Virus Type 1 and 2 and Simian Immunodeficiency Virus

    Article • Journal of Virology, May 2001, ASM Journals

    Professor Stefan Pöhlmann

  242. DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans

    Article • Proceedings of the National Academy of Sciences, February 2001, Proceedings of the National Academy of Sciences

    Professor Stefan Pöhlmann

  243. Natural Proteolytic Processing of Hemofiltrate Cc Chemokine 1 Generates a Potent Cc Chemokine Receptor (Ccr)1 and Ccr5 Agonist with Anti-HIV Properties

    Article • The Journal of Experimental Medicine, November 2000, Rockefeller University Press

    Professor Stefan Pöhlmann

  244. Simian Immunodeficiency Virus Utilizes Human and Sooty Mangabey but Not Rhesus Macaque STRL33 for Efficient Entry

    Article • Journal of Virology, June 2000, ASM Journals

    Professor Stefan Pöhlmann

  245. Co‐receptor Usage of BOB/GPR15 in Addition to CCR5 Has No Significant Effect on Replication of Simian Immunodeficiency Virus In Vivo

    Article • The Journal of Infectious Diseases, November 1999, Oxford University Press (OUP)

    Professor Stefan Pöhlmann, Professor Jonathan Luke Heeney